The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Pathological implication of protein post-translational modifications in cancer
Open accessAbstract
Protein post-translational modifications (PTMs) profoundly influence protein functions and play crucial roles in essentially all cell biological processes. The diverse realm of PTMs and their crosstalk is linked to many critical signaling events involved in neoplastic transformation, carcinogenesis and metastasis. The pathological roles of various PTMs are implicated in all aspects of cancer hallmark functions, cancer metabolism and regulation of tumor microenvironment. Study of PTMs has become an important area in cancer research to understand cancer biology and discover novel biomarkers and therapeutic targets. With a limited scope, this review attempts to discuss some PTMs of high frequency with recognized importance in cancer biology, including phosphorylation, acetylation, glycosylation, palmitoylation and ubiquitination, as well as their implications in clinical applications. These protein modifications are among the most abundant PTMs and profoundly implicated in carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Glycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,788
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Bertozzi, C. R., & Kiessling, A. L. L. (2001) · Science · doi:10.1126/science.1059820 · Cited by 1,939
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
Regulation of cellular metabolism by protein lysine acetylation
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910
Protein Posttranslational Modifications: The Chemistry of Proteome Diversifications
Walsh, C. T., Garneau‐Tsodikova, S., & Gatto, G. J. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501023 · Cited by 1,604
Glycosylation and the Immune System
Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., & Dwek, R. A. (2001) · Science · doi:10.1126/science.291.5512.2370 · Cited by 1,588
Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey
Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.026 · Cited by 1,487
Mechanisms of specificity in protein phosphorylation
Ubersax, J. A., & Ferrell Jr, J. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2203 · Cited by 1,451
Galectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
Ubiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1881 · Cited by 1,433
Classifying Cancers Based on T-cell Infiltration and PD-L1
Teng, M. W. L., Ngiow, S. F., Ribas, A., & Smyth, M. J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0255 · Cited by 1,411
Ubiquitination in disease pathogenesis and treatment
Popovic, D., Vucic, D., & Dikic, I. (2014) · Nature Medicine · doi:10.1038/nm.3739 · Cited by 1,401
Zhang, H., Li, X.-J., Martin, D. B., & Aebersold, R. (2003) · Nature Biotechnology · doi:10.1038/nbt827 · Cited by 1,389
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Revisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 1,245
Palmitoylation: policing protein stability and traffic
Linder, M. E., & Deschenes, R. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2084 · Cited by 1,185
Global histone modification patterns predict risk of prostate cancer recurrence
Seligson, D. B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M., & Kurdistani, S. K. (2005) · Nature · doi:10.1038/nature03672 · Cited by 1,092
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Li, C.-W., Lim, S.-O., Xia, W., Lee, H.-H., Chan, L.-C., Kuo, C.-W., Khoo, K.-H., Chang, S.-S., Cha, J.-H., Kim, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms12632 · Cited by 1,091
Mechanisms of receptor tyrosine kinase activation in cancer
Du, Z., & Lovly, C. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0782-4 · Cited by 1,066
Histone deacetylases and cancer
Glozak, M. A., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210610 · Cited by 1,031
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Santarpia, L., Lippman, S. M., & El-Naggar, A. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645805 · Cited by 1,027
Glycosylation defining cancer malignancy: New wine in an old bottle
Hakomori, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172380699 · Cited by 960
β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis
Dennis, J. W., Laferté, S., Waghorne, C., Breitman, M. L., & Kerbel, R. S. (1987) · Science · doi:10.1126/science.2953071 · Cited by 940
Modulation of cellular processes by histone and non-histone protein acetylation
Shvedunova, M., & Akhtar, A. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00441-y · Cited by 936
Khoury, G. A., Baliban, R. C., & Floudas, C. A. (2011) · Scientific Reports · doi:10.1038/srep00090 · Cited by 935
Lau, K. S., Partridge, E. A., Grigorian, A., Silvescu, C. I., Reinhold, V. N., Demetriou, M., & Dennis, J. W. (2007) · Cell · doi:10.1016/j.cell.2007.01.049 · Cited by 914
Post-translational modifications in signal integration
Deribe, Y. L., Pawson, T., & Dikic, I. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1842 · Cited by 876
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820
Role of Glycosylation in Development
Haltiwanger, R. S., & Lowe, J. B. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074043 · Cited by 757
The role of ubiquitination in tumorigenesis and targeted drug discovery
Deng, L., Meng, T., Chen, L., Wei, W., & Wang, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0107-0 · Cited by 744
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation
Brooks, C. L., & Gu, W. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00003-6 · Cited by 742
Mammalian glycosylation in immunity
Marth, J. D., & Grewal, P. K. (2008) · Nature Reviews Immunology · doi:10.1038/nri2417 · Cited by 712
Nørregaard Jensen, O. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.12.009 · Cited by 624
Bause, E. (1983) · Biochemical Journal · doi:10.1042/bj2090331 · Cited by 604
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
Li, C.-W., Lim, S.-O., Chung, E. M., Kim, Y.-S., Park, A. H., Yao, J., Cha, J.-H., Xia, W., Chan, L.-C., Kim, T., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.009 · Cited by 602
Status of Large-scale Analysis of Post-translational Modifications by Mass Spectrometry
Olsen, J. V., & Mann, M. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o113.034181 · Cited by 591
Acetylation of the C Terminus of Ku70 by CBP and PCAF Controls Bax-Mediated Apoptosis
Cohen, H. Y., Lavu, S., Bitterman, K. J., Hekking, B., Imahiyerobo, T. A., Miller, C., Frye, R., Ploegh, H., Kessler, B. M., & Sinclair, D. A. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00094-2 · Cited by 578
Decoding signalling networks by mass spectrometry-based proteomics
Choudhary, C., & Mann, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2900 · Cited by 571
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570
Glycosphingolipids as Tumor-Associated and Differentiation Markers 56
(1983) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/71.2.231 · Cited by 569
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Mereiter, S., Balmaña, M., Campos, D., Gomes, J., & Reis, C. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.06.006 · Cited by 565
Regulating the regulator: post-translational modification of RAS
Ahearn, I. M., Haigis, K., Bar-Sagi, D., & Philips, M. R. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3255 · Cited by 557
Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins
Wollscheid, B., Bausch-Fluck, D., Henderson, C., O'Brien, R., Bibel, M., Schiess, R., Aebersold, R., & Watts, J. D. (2009) · Nature Biotechnology · doi:10.1038/nbt.1532 · Cited by 547
Lundby, A., Lage, K., Weinert, B. T., Bekker-Jensen, D. B., Secher, A., Skovgaard, T., Kelstrup, C. D., Dmytriyev, A., Choudhary, C., Lundby, C., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.07.006 · Cited by 547
p53 post-translational modification: deregulated in tumorigenesis
Dai, C., & Gu, W. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.09.002 · Cited by 523
Hallmarks of glycosylation in cancer
Munkley, J., & Elliott, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8155 · Cited by 521
Cell surface protein glycosylation in cancer
Christiansen, M. N., Chik, J., Lee, L., Anugraham, M., Abrahams, J. L., & Packer, N. H. (2014) · PROTEOMICS · doi:10.1002/pmic.201300387 · Cited by 518
Elsheikh, S. E., Green, A. R., Rakha, E. A., Powe, D. G., Ahmed, R. A., Collins, H. M., Soria, D., Garibaldi, J. M., Paish, C. E., Ammar, A. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3907 · Cited by 511
Large-scale profiling of protein palmitoylation in mammalian cells
Martin, B. R., & Cravatt, B. F. (2009) · Nature Methods · doi:10.1038/nmeth.1293 · Cited by 510
Uncovering global SUMOylation signaling networks in a site-specific manner
Hendriks, I. A., D'Souza, R. C. J., Yang, B., Verlaan-de Vries, M., Mann, M., & Vertegaal, A. C. O. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2890 · Cited by 486
The selectins and their ligands
Rosen, S. D., & Bertozzi, C. R. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90092-2 · Cited by 470
Mutations and mechanisms of WNT pathway tumour suppressors in cancer
Bugter, J. M., Fenderico, N., & Maurice, M. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00307-z · Cited by 466
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter
Luo, G., Jin, K., Deng, S., Cheng, H., Fan, Z., Gong, Y., Qian, Y., Huang, Q., Ni, Q., Liu, C., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188409 · Cited by 446
Protein palmitoylation and cancer
Ko, P., & Dixon, S. J. (2018) · EMBO reports · doi:10.15252/embr.201846666 · Cited by 431
The Roles of Post-translational Modifications in the Context of Protein Interaction Networks
Duan, G., & Walther, D. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004049 · Cited by 430
SUMO and the robustness of cancer
Seeler, J.-S., & Dejean, A. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.143 · Cited by 429
Liu, Y.-C., Yen, H.-Y., Chen, C.-Y., Chen, C.-H., Cheng, P.-F., Juan, Y.-H., Chen, C.-H., Khoo, K.-H., Yu, C.-J., Yang, P.-C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107385108 · Cited by 424
Glycosylation: Heterogeneity and the 3D Structure of Proteins
Rudd, P. M., & Dwek, R. A. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709085144 · Cited by 424
Jung, Y.-S., & Park, J.-I. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0380-6 · Cited by 419
Fatty Acid Synthase: An Emerging Target in Cancer
Fhu, C. W., & Ali, A. (2020) · Molecules · doi:10.3390/molecules25173935 · Cited by 392
Zhao, Y., & Jensen, O. N. (2009) · PROTEOMICS · doi:10.1002/pmic.200900398 · Cited by 384
Control of Smad7 Stability by Competition between Acetylation and Ubiquitination
Grönroos, E., Hellman, U., Heldin, C.-H., & Ericsson, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00639-1 · Cited by 383
The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress
Morris, J. R., Boutell, C., Keppler, M., Densham, R., Weekes, D., Alamshah, A., Butler, L., Galanty, Y., Pangon, L., Kiuchi, T., et al. (2009) · Nature · doi:10.1038/nature08593 · Cited by 375
Cell cycle on the crossroad of tumorigenesis and cancer therapy
Liu, J., Peng, Y., & Wei, W. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.07.001 · Cited by 372
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366
Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD
Kudelka, M. R., Stowell, S. R., Cummings, R. D., & Neish, A. S. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0331-7 · Cited by 355
The c-MYC Oncoprotein Is a Substrate of the Acetyltransferases hGCN5/PCAF and TIP60
Patel, J. H., Du, Y., Ard, P. G., Phillips, C., Carella, B., Chen, C.-J., Rakowski, C., Chatterjee, C., Lieberman, P. M., Lane, W. S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10826-10834.2004 · Cited by 354
Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
Cox, A. D., Der, C. J., & Philips, M. R. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3214 · Cited by 351
Zhao, D., Zou, S.-W., Liu, Y., Zhou, X., Mo, Y., Wang, P., Xu, Y.-H., Dong, B., Xiong, Y., Lei, Q.-Y., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.005 · Cited by 345
Site-specific analysis of protein S-acylation by resin-assisted capture
Forrester, M. T., Hess, D. T., Thompson, J. W., Hultman, R., Moseley, M. A., Stamler, J. S., & Casey, P. J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d011106 · Cited by 340
Phosphorylation: Implications in Cancer
Singh, V., Ram, M., Kumar, R., Prasad, R., Roy, B. K., & Singh, K. K. (2017) · The Protein Journal · doi:10.1007/s10930-017-9696-z · Cited by 337
Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks
Peixoto, A., Relvas-Santos, M., Azevedo, R., Santos, L. L., & Ferreira, J. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00380 · Cited by 334
Labeling and quantifying sites of protein palmitoylation
Drisdel, R. C., & Green, W. N. (2004) · BioTechniques · doi:10.2144/04362rr02 · Cited by 325
Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments
Yip, H. Y. K., & Papa, A. (2021) · Cells · doi:10.3390/cells10030659 · Cited by 316
Andrianifahanana, M., Moniaux, N., & Batra, S. K. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.01.002 · Cited by 314
Immature truncated O-glycophenotype of cancer directly induces oncogenic features
Radhakrishnan, P., Dabelsteen, S., Madsen, F. B., Francavilla, C., Kopp, K. L., Steentoft, C., Vakhrushev, S. Y., Olsen, J. V., Hansen, L., Bennett, E. P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406619111 · Cited by 313
Zhao, L., Zhang, C., Luo, X., Wang, P., Zhou, W., Zhong, S., Xie, Y., Jiang, Y., Yang, P., Tang, R., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.04.006 · Cited by 313
Migrating into the tumor: a roadmap for T cells
van der Woude, L. L., Gorris, M. A. J., Halilovic, A., Figdor, C. G., & de Vries, I. J. M. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.006 · Cited by 307
Evaluation of the serum N ‐linked glycome for the diagnosis of cancer and chronic inflammation
Arnold, J. N., Saldova, R., Hamid, U. M. A., & Rudd, P. M. (2008) · PROTEOMICS · doi:10.1002/pmic.200800163 · Cited by 307
Füllgrabe, J., Kavanagh, E., & Joseph, B. (2011) · Oncogene · doi:10.1038/onc.2011.121 · Cited by 304
Large-scale identification of ubiquitination sites by mass spectrometry
Udeshi, N. D., Mertins, P., Svinkina, T., & Carr, S. A. (2013) · Nature Protocols · doi:10.1038/nprot.2013.120 · Cited by 296
Itkonen, H. M., Minner, S., Guldvik, I. J., Sandmann, M. J., Tsourlakis, M. C., Berge, V., Svindland, A., Schlomm, T., & Mills, I. G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0549 · Cited by 292
Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy
Hsu, J.-M., Li, C.-W., Lai, Y.-J., & Hung, M.-C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1892 · Cited by 286
Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
Läubli, H., & Borsig, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02120 · Cited by 282
Global Histone Modifications Predict Prognosis of Resected Non–Small-Cell Lung Cancer
Barlési, F., Giaccone, G., Gallegos-Ruiz, M. I., Loundou, A., Span, S. W., Lefesvre, P., Kruyt, F. A. E., & Rodriguez, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2599 · Cited by 280
Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation
Li, H., Kobayashi, M., Blonska, M., You, Y., & Lin, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600620200 · Cited by 277
Chen, B., Sun, Y., Niu, J., Jarugumilli, G. K., & Wu, X. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.05.003 · Cited by 271
Yang, W., Di Vizio, D., Kirchner, M., Steen, H., & Freeman, M. R. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800448-mcp200 · Cited by 268
Mass Spectrometry Based Glycoproteomics—From a Proteomics Perspective
Pan, S., Chen, R., Aebersold, R., & Brentnall, T. A. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r110.003251 · Cited by 267
Self-citationPhosphoproteomics in the Age of Rapid and Deep Proteome Profiling
Riley, N. M., & Coon, J. J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04123 · Cited by 265
Simple Sugars to Complex Disease—Mucin-Type O-Glycans in Cancer
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2014.11.002 · Cited by 260
Nadolski, M. J., & Linder, M. E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.06056.x · Cited by 251
Structural glycomics using hydrophilic interaction chromatography (HILIC) with mass spectrometry
Wuhrer, M., de Boer, A. R., & Deelder, A. M. (2009) · Mass Spectrometry Reviews · doi:10.1002/mas.20195 · Cited by 242
Deciphering a global network of functionally associated post‐translational modifications
Minguez, P., Parca, L., Diella, F., Mende, D. R., Kumar, R., Helmer‐Citterich, M., Gavin, A., van Noort, V., & Bork, P. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.31 · Cited by 233
Van Den Broeck, A., Brambilla, E., Moro-Sibilot, D., Lantuejoul, S., Brambilla, C., Eymin, B., Khochbin, S., & Gazzeri, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0869 · Cited by 232
Suppression of Cancer Cell Growth by Promoting Cyclin D1 Degradation
Shan, J., Zhao, W., & Gu, W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.018 · Cited by 229
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
Riley, N. M., Bertozzi, C. R., & Pitteri, S. J. (2021) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r120.002277 · Cited by 227
Hallmarks of cancer—the new testament
Senga, S. S., & Grose, R. P. (2021) · Open Biology · doi:10.1098/rsob.200358 · Cited by 221
Glycomics: a pathway to a class of new and improved therapeutics
Shriver, Z., Raguram, S., & Sasisekharan, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1521 · Cited by 220
dbPTM in 2019: exploring disease association and cross-talk of post-translational modifications
Huang, K.-Y., Lee, T.-Y., Kao, H.-J., Ma, C.-T., Lee, C.-C., Lin, T.-H., Chang, W.-C., & Huang, H.-D. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1074 · Cited by 220
Posttranslational Protein Modifications
Krueger, K. E., & Srivastava, S. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r600009-mcp200 · Cited by 215
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics
Kirwan, A., Utratna, M., O’Dwyer, M. E., Joshi, L., & Kilcoyne, M. (2015) · BioMed Research International · doi:10.1155/2015/490531 · Cited by 215
Chemical Probes for the Rapid Detection of Fatty-Acylated Proteins in Mammalian Cells
Hang, H. C., Geutjes, E.-J., Grotenbreg, G., Pollington, A. M., Bijlmakers, M. J., & Ploegh, H. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0685001 · Cited by 205
Quantitative measurements of N‐linked glycoproteins in human plasma by SWATH‐MS
Liu, Y., Hüttenhain, R., Surinova, S., Gillet, L. C., Mouritsen, J., Brunner, R., Navarro, P., & Aebersold, R. (2013) · PROTEOMICS · doi:10.1002/pmic.201200417 · Cited by 204
KRAS4A directly regulates hexokinase 1
Amendola, C. R., Mahaffey, J. P., Parker, S. J., Ahearn, I. M., Chen, W.-C., Zhou, M., Court, H., Shi, J., Mendoza, S. L., Morten, M. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1832-9 · Cited by 203
Lysine acetylation and cancer: A proteomics perspective
Gil, J., Ramírez-Torres, A., & Encarnación-Guevara, S. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2016.10.003 · Cited by 184
Kannagi, R., Yin, J., Miyazaki, K., & Izawa, M. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.10.007 · Cited by 180
Deciphering post‐translational modification codes
Lothrop, A. P., Torres, M. P., & Fuchs, S. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.047 · Cited by 180
Mass Spectrometric Detection of Tissue Proteins in Plasma
Zhang, H., Liu, A. Y., Loriaux, P., Wollscheid, B., Zhou, Y., Watts, J. D., & Aebersold, R. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600160-mcp200 · Cited by 180
The Role of Electron Transfer Dissociation in Modern Proteomics
Riley, N. M., & Coon, J. J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04810 · Cited by 180
Thaysen-Andersen, M., Packer, N. H., & Schulz, B. L. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o115.057638 · Cited by 178
Mucin expression profile in pancreatic cancer and the precursor lesions
Nagata, K., Horinouchi, M., Saitou, M., Higashi, M., Nomoto, M., Goto, M., & Yonezawa, S. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1169-2 · Cited by 168
Features and regulation of non-enzymatic post-translational modifications
Harmel, R., & Fiedler, D. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2575 · Cited by 166
Pagel, O., Loroch, S., Sickmann, A., & Zahedi, R. P. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1042867 · Cited by 164
Phosphorylation-Mediated Regulation of Alternative Splicing in Cancer
Naro, C., & Sette, C. (2013) · International Journal of Cell Biology · doi:10.1155/2013/151839 · Cited by 164
Glycomics using mass spectrometry
Wuhrer, M. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9376-3 · Cited by 163
Pinho, S., Marcos, N. T., Ferreira, B., Carvalho, A. S., Oliveira, M. J., Santos-Silva, F., Harduin-Lepers, A., & Reis, C. A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.08.010 · Cited by 162
Guo, H., Lee, I., Kamar, M., & Pierce, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308837200 · Cited by 160
TRIM25 in the Regulation of the Antiviral Innate Immunity
Martin‐Vicente, M., Medrano, L. M., Resino, S., García‐Sastre, A., & Martínez, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01187 · Cited by 160
TMX1 determines cancer cell metabolism as a thiol-based modulator of ER–mitochondria Ca2+ flux
Raturi, A., Gutiérrez, T., Ortiz-Sandoval, C. G., Ruangkittisakul, A., Herrera-Cruz, M. S., Rockley, J. P., Gesson, K., Ourdev, D., Lou, P., Lucchinetti, E., et al. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201512077 · Cited by 159
Potapenko, I. O., Haakensen, V. D., Lüders, T., Helland, Å., Bukholm, I., Sørlie, T., Kristensen, V. N., Lingjærde, O. C., & Børresen-Dale, A.-L. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2009.12.001 · Cited by 158
Lumpkin, R. J., Gu, H., Zhu, Y., Leonard, M., Ahmad, A. S., Clauser, K. R., Meyer, J. G., Bennett, E. J., & Komives, E. A. (2017) · Nature Communications · doi:10.1038/s41467-017-01271-3 · Cited by 153
Pinho, S. S., Figueiredo, J., Cabral, J., Carvalho, S., Dourado, J., Magalhães, A., Gärtner, F., Mendonça, A. M., Isaji, T., Gu, J., et al. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.021 · Cited by 152
Acetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and Cancer
Gong, F., Chiu, L.-Y., & Miller, K. M. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006272 · Cited by 152
ABHD10 is an S-depalmitoylase affecting redox homeostasis through peroxiredoxin-5
Cao, Y., Qiu, T., Kathayat, R. S., Azizi, S., Thorne, A. K., Ahn, D. J., Fukata, Y., Fukata, M., Rice, P. A., & Dickinson, B. C. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0399-y · Cited by 149
Recent Advances in the Analysis of Complex Glycoproteins
Gaunitz, S., Nagy, G., Pohl, N. L. B., & Novotný, M. V. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04343 · Cited by 137
Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling
Lamoliatte, F., Caron, D., Durette, C., Mahrouche, L., Maroui, M. A., Caron-Lizotte, O., Bonneil, É., Chelbi‐Alix, M. K., & Thibault, P. (2014) · Nature Communications · doi:10.1038/ncomms6409 · Cited by 136
Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis
Chandler, K. B., Costello, C. E., & Rahimi, N. (2019) · Cells · doi:10.3390/cells8060544 · Cited by 136
Regulation of RAS oncogenicity by acetylation
Yang, M. H., Nickerson, S., Kim, E. T., Liot, C., Laurent, G., Spang, R., Philips, M. R., Shan, Y., Shaw, D. E., Bar‐Sagi, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201487109 · Cited by 133
Palmitoylation and localisation of RAS isoforms are modulated by the hypervariable linker domain
Laude, A., & Prior, I. A. (2008) · Journal of Cell Science · doi:10.1242/jcs.020107 · Cited by 131
Brunner, A. M., Lössl, P., Liu, F., Huguet, R., Mullen, C., Yamashita, M., Zabrouskov, V., Makarov, A., Altelaar, M. A. F., & Heck, A. J. R. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00162 · Cited by 123
“RAF” neighborhood: Protein–protein interaction in the Raf/Mek/Erk pathway
Cseh, B., Doma, E., & Baccarini, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.06.025 · Cited by 121
Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets
Chugh, S., Gnanapragassam, V. S., Jain, M., Rachagani, S., Ponnusamy, M. P., & Batra, S. K. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.08.003 · Cited by 120
Hutchinson, W. L., Du, M., Johnson, P. J., & Williams, R. L. (1991) · Hepatology · doi:10.1002/hep.1840130412 · Cited by 114
Mínguez, P., Letunić, I., Parca, L., García‐Alonso, L., Dopazo, J., Huerta‐Cepas, J., & Bork, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1081 · Cited by 111
Dimeric sialyl-Lex expression in gastric carcinoma correlates with venous invasion and poor outcome
Amado, M., Carneiro, F., Seixas, M., Clausen, H., & Sobrinho-Simões, M. A. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70529-3 · Cited by 108
Pan, S., Chen, R., Tamura, Y., Crispin, D. A., Lai, L. A., May, D., McIntosh, M. W., Goodlett, D. R., & Brentnall, T. A. (2014) · Journal of Proteome Research · doi:10.1021/pr4010184 · Cited by 107
Self-citationThe Coming of Age of Phosphoproteomics—from Large Data Sets to Inference of Protein Functions
Roux, P. P., & Thibault, P. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r113.032862 · Cited by 105
WIDENING THE BOTTLENECK OF PHOSPHOPROTEOMICS: EVOLVING STRATEGIES FOR PHOSPHOPEPTIDE ENRICHMENT
Low, T. Y., Mohtar, M. A., Lee, P. Y., Omar, N., Zhou, H., & Ye, M. (2020) · Mass Spectrometry Reviews · doi:10.1002/mas.21636 · Cited by 104
Kannagi, R., Sakuma, K., Miyazaki, K., Lim, K., Yusa, A., Yin, J., & Izawa, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01455.x · Cited by 100
Li, T., Liu, M., Feng, X., Wang, Z., Das, I., Xu, Y., Zhou, X., Sun, Y., Guan, K., Xiong, Y., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.531640 · Cited by 100
Posttranslational Regulation of Smads
Xu, P., Lin, X., & Feng, X. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022087 · Cited by 100
Bhattacharjee, S., & Nandi, S. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0195-9 · Cited by 100
Hajji, N., Wallenborg, K., Engskog‐Vlachos, P., Füllgrabe, J., Hermanson, O., & Joseph, B. (2010) · Oncogene · doi:10.1038/onc.2009.505 · Cited by 98
Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics
Kaypee, S., Sudarshan, D., Shanmugam, M. K., Mukherjee, D., Sethi, G., & Kundu, T. K. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.011 · Cited by 97
Global, site-specific analysis of neuronal protein S-acylation
Collins, M. O., Woodley, K. T., & Choudhary, J. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-04580-1 · Cited by 97
Rodenburg, R. N. P., Snijder, J., van de Waterbeemd, M., Schouten, A., Granneman, J. C. M., Heck, A. J. R., & Gros, P. (2017) · Nature Communications · doi:10.1038/s41467-017-01461-z · Cited by 97
Developing Targeted Therapies That Exploit Aberrant Histone Ubiquitination in Cancer
Jeusset, L. M., & McManus, K. J. (2019) · Cells · doi:10.3390/cells8020165 · Cited by 97
Leeming, D. J., Bay‐Jensen, A., Vassiliadis, E., Larsen, M. R., Henriksen, K., & Karsdal, M. A. (2011) · Biomarkers · doi:10.3109/1354750x.2011.557440 · Cited by 96
Garrido, P., Morán, J., Alonso, A., Gonzalez, S. R., & González, C. (2013) · Endocrinology · doi:10.1210/en.2012-1558 · Cited by 96
Palmitoylation of proteins in cancer
Resh, M. D. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160233 · Cited by 95
Crosstalk of intracellular post-translational modifications in cancer
Wu, Z., Huang, R., & Yuan, L. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108138 · Cited by 94
RAS, wanted dead or alive: Advances in targeting RAS mutant cancers
Stalnecker, C. A., & Der, C. J. (2020) · Science Signaling · doi:10.1126/scisignal.aay6013 · Cited by 90
Glyco-DIA: a method for quantitative O-glycoproteomics with in silico-boosted glycopeptide libraries
Ye, Z., Mao, Y., Clausen, H., & Vakhrushev, S. Y. (2019) · Nature Methods · doi:10.1038/s41592-019-0504-x · Cited by 89
Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
Wu, D., Qiu, Y., Jiao, Y., Qiu, Z., & Liu, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.560487 · Cited by 89
Ke, M., Shen, H.-N., Wang, L., Luo, S., Lin, L., Yang, J. W., & Tian, R. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41448-5_17 · Cited by 87
MS‐based glycomics and glycoproteomics methods enabling isomeric characterization
Peng, W., Reyes, C. D. G., Gautam, S., Yu, A., Cho, B. G., Goli, M., Donohoo, K. B., Mondello, S., Kobeissy, F. H., & Mechref, Y. S. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21713 · Cited by 87
Role of the LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells (Review)
Li, N., Huang, D., Lü, N., & Luo, L. (2015) · Oncology Reports · doi:10.3892/or.2015.4288 · Cited by 85
Acetylation and deacetylation in cancer stem-like cells
Liu, N., Li, S., Wu, N., & Cho, K. (2017) · Oncotarget · doi:10.18632/oncotarget.19167 · Cited by 84
Temporal Profiling Establishes a Dynamic S-Palmitoylation Cycle
Won, S. J., & Martin, B. R. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00157 · Cited by 81
Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites
Thinon, E., Fernandez, J., Molina, H., & Hang, H. C. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00002 · Cited by 80
Glycomics and Mass Spectrometry
Morelle, W., & Michalski, J.-C. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054546897 · Cited by 78
Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins
Hoffmann, M., Marx, K., Reichl, U., Wuhrer, M., & Rapp, E. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.053546 · Cited by 78
Sanctis, F. D., Sandri, S., Ferrarini, G., Pagliarello, I., Sartoris, S., Ugel, S., Marigo, I., Molon, B., & Bronte, V. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00069 · Cited by 76
Roles of the Phosphorylation of Transcriptional Factors in Epithelial-Mesenchymal Transition
Xu, R., Won, J.-Y., Kim, C.-H., Kim, D., & Yim, H. (2019) · Journal of Oncology · doi:10.1155/2019/5810465 · Cited by 76
Vercoutter‐Edouart, A., Slomianny, M., Dekeyzer-Beseme, O., Haeuw, J., & Michalski, J. (2008) · PROTEOMICS · doi:10.1002/pmic.200800151 · Cited by 74
Post-translational modification of RAS proteins
Campbell, S. L., & Philips, M. R. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.06.015 · Cited by 72
Glycoproteins and glycoproteomics in pancreatic cancer
Pan, S., Brentnall, T. A., & Chen, R. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i42.9288 · Cited by 70
Self-citationMass spectrometry‐driven phosphoproteomics: patterning the systems biology mosaic
Jünger, M. A., & Aebersold, R. H. (2013) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.121 · Cited by 67
Narimatsu, H., Kaji, H., Vakhrushev, S. Y., Clausen, H., Zhang, H., Noro, E., Togayachi, A., Nagai‐Okatani, C., Kuno, A., Zou, X., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00515 · Cited by 67
Trougakos, I. P., Sesti, F., Tsakiri, E. N., & Gorgoulis, V. G. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.02.024 · Cited by 65
Large-scale intact glycopeptide identification by Mascot database search
Bollineni, R. C., Koehler, C. J., Gislefoss, R. E., Anonsen, J. H., & Thiede, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-20331-2 · Cited by 65
Proteome-wide identification of SUMO modification sites by mass spectrometry
Tammsalu, T., Matić, I., Jaffray, E., Ibrahim, A. F. M., Tatham, M. H., & Hay, R. T. (2015) · Nature Protocols · doi:10.1038/nprot.2015.095 · Cited by 64
SCFβ-TrCP1 Controls Smad4 Protein Stability in Pancreatic Cancer Cells
Wan, M., Huang, J., Jhala, N. C., Tytler, E. M., Yang, L. F., Vickers, S. M., Tang, Y., Lu, C., Wang, N., & Cao, X. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62356-5 · Cited by 62
Drug design targeting active posttranslational modification protein isoforms
Meng, F., Liang, Z. T., Zhao, K., & Luo, C. (2020) · Medicinal Research Reviews · doi:10.1002/med.21774 · Cited by 61
c‐Abl acetylation by histone acetyltransferases regulates its nuclear–cytoplasmic localization
di Bari, M. G., Ciuffini, L., Mingardi, M., Testi, R., Soddu, S., & Barilà, D. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400700 · Cited by 60
Phosphoproteomics with Activated Ion Electron Transfer Dissociation
Riley, N. M., Hebert, A. S., Dürnberger, G., Stanek, F., Mechtler, K., Westphall, M. S., & Coon, J. J. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00212 · Cited by 59
Ubiquitin-Modifying Enzymes and Regulation of the Inflammasome
Kattah, M. G., Malynn, B. A., & Ma, A. I. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.10.001 · Cited by 59
Lan, R., & Wang, Q. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03296-x · Cited by 59
Post-translational modification of KRAS: potential targets for cancer therapy
Wang, W., Yuan, T., Qian, M., Yan, F., Yang, L., He, Q., Yang, B., Lu, J., & Zhu, H. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00542-y · Cited by 59
USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis
Dong, L., Yu, L., Bai, C., Liu, L., Long, H., Shi, L., & Lin, Z. (2018) · Oncogene · doi:10.1038/s41388-018-0137-z · Cited by 56
Watanabe, N., & Osada, H. (2012) · Current Drug Targets · doi:10.2174/138945012803530035 · Cited by 52
Targeting Histone Acetylation: Readers and Writers in Leukemia and Cancer
Benton, C. B., Fiskus, W. C., & Bhalla, K. N. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000284 · Cited by 52
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development
Shankar, S., Tien, J. C.-Y., Siebenaler, R. F., Chugh, S., Dommeti, V. L., Zelenka-Wang, S., Waninger, J. J., Juckette, K. M., Xu, A., Wang, X.-M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16309-2 · Cited by 51
Harada, T., Sada, R., Osugi, Y., Matsumoto, S., Matsuda, T., Hayashi, M., Nagai, T., Harada, A., & Kikuchi, A. (2020) · Journal of Cell Science · doi:10.1242/jcs.249045 · Cited by 51
Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment
Chang, S. C., & Ding, J. L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.08.002 · Cited by 50
Glut4 palmitoylation at Cys223 plays a critical role in Glut4 membrane trafficking
Ren, W., Sun, Y., & Du, K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.094 · Cited by 47
Proteomic analysis of phosphorylation in cancer
Ruprecht, B., & Lemeer, S. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.901156 · Cited by 44
Proteomics insights into DNA damage response and translating this knowledge to clinical strategies
von Stechow, L., & Olsen, J. V. (2016) · PROTEOMICS · doi:10.1002/pmic.201600018 · Cited by 44
Trost, M., Bridon, G., Desjardins, M., & Thibault, P. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20297 · Cited by 41
Cited by
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Liu, R., Wu, J., Guo, H., Yao, W., Li, S., Lu, Y., Jia, Y., Liang, X., Tang, J., & Zhang, H. (2023) · MedComm · doi:10.1002/mco2.292 · Cited by 264
Systematic identification of structure-specific protein–protein interactions
(2024) · doi:10.1038/s44320-024-00037-6 · Cited by 34
Sun, X., Zhang, K., Peng, X., Zhou, P., Qu, C., Yang, L., & Shen, L. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216158 · Cited by 21
Targeted protein modification as a paradigm shift in drug discovery
Amirian, R., Azadi Badrbani, M., Izadi, Z., Samadian, H., Bahrami, G., Sarvari, S., Abdolmaleki, S., Nabavi, S. M., Derakhshankhah, H., & Jaymand, M. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115765 · Cited by 18
Metadata
- Authors
- Pan, S., & Chen, R.
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 86
- Pages
- 101097
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W4223515782
- Cited by
- 263
- References
- 220
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.